Quantcast

Latest Hematological malignancy Stories

2014-04-22 23:00:54

Civic Duty, cofounded by Julian Omidi and Dr. Michael Omidi, is donating to the Leukemia & Lymphoma Society’s Man and Woman of the Year campaigns. Those in the Sacramento area are invited to also support this worthy charity by attending a special art auction and show with performance painter David Garibaldi on April 24, 2014, with all proceeds going to help fund new research in hopes of curing this devastating cancer. (PRWEB) April 22, 2014 Civic Duty applauds the tireless...

2014-04-13 23:01:08

Transparency Market Research Report Added "Blood Disease Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse Full Report: http://www.transparencymarketresearch.com/blood-disease-treatment-drugs.html. Albany, New York, USA (PRWEB) April 13, 2014 Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and...

2014-03-27 08:35:29

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/48gc9x/therapeutic_class ) has announced the addition of the "Therapeutic Class Overview: Treating Refractory Hematological Malignancies" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable...

2014-03-26 08:23:02

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pt8tl4/treating ) has announced the addition of the "Concise Analysis of New Methods for Treating Refractory Hematological Malignancies - Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Targeting unmet needs in the treatment of cancer through innovative drug development strategies have...

2014-03-26 08:22:56

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lnx8jm/treating ) has announced the addition of the "Concise Analysis on Treating Refractory Hematological Malignancies for Multiple Myeloma" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) "Concise Analysis on Treating Refractory Hematological Malignancies for Multiple Myeloma", provides an overview of the therapies for Multiple Myeloma (Newly...

2014-03-20 23:01:51

Kanti Rai, MD, and Jacqueline Barrientos, MD, comment on study of new leukemia therapy. Lake Success, NY (PRWEB) March 20, 2014 Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the March 20 edition of the New England Journal of Medicine, the North Shore-LIJ Health System announced today. CLL is one of the most common forms of blood cancers, usually affecting...

2014-03-10 16:32:44

WHITE PLAINS, N.Y., March 10, 2014 /PRNewswire/ -- Today The Leukemia & Lymphoma Society (LLS) is pleased to announce expanded hours for its Information Resource Center (IRC), a toll-free call center staffed with master's level healthcare professionals equipped with the latest information on all of the blood cancers. Beginning today the hours of service will be 9 a.m. to 9 p.m. ET, Monday through Friday. The IRC can be reached at (800) 955-4572. The call center immediately can...

2014-03-10 12:24:08

WASHINGTON, March 10, 2014 /PRNewswire-USNewswire/ -- A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* published online today in Blood, the journal of the American Society of Hematology. Patients with blood cancer are typically administered a combination of chemotherapy and immunotherapy, the latter using...

2014-03-06 23:32:39

SuperSlow Zone owner, Kurt Jacquin of Woodstone, Texas was recently featured in The International Business Times for his support of the Leukemia and Lymphoma Society. Woodstone, TX (PRWEB) March 05, 2014 SuperSlow Zone owner Kurt Jacquin of Woodstone, Texas, was recently featured in The International Business Times for his support of the Leukemia and Lymphoma Society. The Leukemia and Lymphoma Society is a not-for-profit organization dedicated to funding blood cancer research and...

2014-02-12 16:26:29

CLL is second indication approved by FDA for ibrutinib; previously approved for mantle cell lymphoma patients WHITE PLAINS, N.Y., Feb. 12, 2014 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with chronic lymphocytic leukemia (CLL) is a significant advance for patients with this blood cancer. Ibrutinib received FDA approval in November to treat patients with mantle cell lymphoma (MCL) who had previously been treated with one...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'